Failed Fed study on Indapamide MR [Study As­sess­ment]

posted by Clarc Homepage – Romania, 2013-11-19 12:04 (4599 d 05:22 ago) – Posting: # 11911
Views: 16,092

Dear all

We have just performed a 2x2x2 fed state study with 26 volunteers on indapamide MR. This generic has already passed the fasting study a few years ago. The dissolution tests are ok.
However in the fed study, the AUC passed, but the Cmax failed:

AUC:
Reference Confidence Interval:            [  0.8,      1.25   ]
Geomean Ratio (Test/Reference) = 0.930233
90% standard confidence interval
(around the ratio:[test form]/[ref form])=[  0.83186,  1.0402 ]
t(0.05 - 24df) = 1.7109


Cmax
Reference Confidence Interval:            [  0.8,      1.25   ]
Geomean Ratio (Test/Reference) = 0.680132
90% standard confidence interval
(around the ratio:[test form]/[ref form])=[  0.61796,  0.74855]
t(0.05 - 24df) = 1.7109


In your opinion this failure of Cmax is caused by the formulation, or is there something else with influence on our results?

Thanks


Edit: Category changed. [Helmut]

I'm always tryin' to do something new, tryin' to look like a beginner.
Meshell Ndegeocello

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
125 visitors (0 registered, 125 guests [including 16 identified bots]).
Forum time: 18:26 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5